Phase II Clinical Trials CROs in United States
38 published
38 published CROs match Phase II Clinical Trials in United States.
Locations in this set include United States, United Kingdom, India, Australia, China, and Canada.
Capabilities that show up most often in this set: Small Molecule, Biologics (Other), Gene Therapy, Vaccine, and Biologics (Monoclonal Antibodies).
Matching companies
Aliri BioanalysisBioanalytical CRO specializing in PK/PD, biomarker, and spatial imaging services across discovery through Phase 3 clinical trials, with 20+ years of regulatory expertise.
AltasciencesMid-size early phase CRO/CDMO in Canada and the U.S. offering preclinical safety testing, clinical pharmacology (Phase I–II), bioanalysis, research services, and manufacturing with integrated capabilities.
CTI Clinical Trial and Consulting ServicesFull-service CRO founded in 1999 providing therapeutic expertise across clinical trial and consulting services to pharmaceutical and biotechnology companies.
CelerionGlobal CRO specializing in early-phase clinical research and bioanalytical sciences with 650+ beds across 30 countries and 50+ years of experience.
CertaraCertara transforms drug development with proprietary biosimulation software, predictive modeling, and AI-driven services spanning discovery through commercialization. Serving 2,400+ biopharmaceutical companies and regulatory agencies across 70 countries, Certara's model-informed drug development (MIDD) platform accelerates clinical and regulatory decision-making.
ClinilabsClinilabs is the leading CNS-focused CRO with 25+ years of expertise in neurotherapeutic clinical trials, offering Phase 1–4 trial management, early-phase development, clinical research units, and MedTech device expertise across psychiatry, neurology, substance use, and rare CNS disorders.
Cognitive Research CorporationExclusively focused CNS contract research organization running Phase I-III neuroscience trials, with driving simulation for assessing how medications affect driving safety. Offers clinical trial management, trial design, data management, biostatistics, and medical writing to sponsors.
ERGOMED GroupGlobal, full-service CRO specializing in oncology and rare disease clinical development, with complementary pharmacovigilance and QA consulting brands.
Emerald ClinicalGlobal clinical research organization with 25+ years of expertise, headquartered in Singapore with operations across Asia-Pacific, EMEA, and the Americas. Specializes in renal, oncology, cardiovascular, and early-phase research with deep scientific leadership and proven operational excellence.- Ergomed Clinical ResearchErgomed is a specialized CRO with 25+ years of experience delivering oncology, rare disease, and complex clinical trial solutions across all phases globally, backed by a team of 100+ MDs and PhDs.
ExperTrialsEuropean-based full-service CRO supporting biotech and medtech companies from Phase I through Phase IV and market access, with 80+ senior clinical research associates across Europe and the USA.
FortreaFortrea is a leading CRO advancing clinical trials through patient-focused clinical solutions that accelerate clinical development and drive trial success.
ICON plcICON is a global clinical research organization providing full-service drug development and clinical trial solutions across early phase through post-marketing, including clinical operations, bioanalytical labs, cardiac safety, medical imaging, and regulatory affairs.
Innovate ResearchIndian CRO providing end-to-end clinical trial services (Phase I–IV), regulatory support, medical writing, biostatistics, data management, and biospecimen procurement across pharmaceuticals, biologics, medical devices, and nutraceuticals.- JSS Medical ResearchFull-service CRO with over 30 years of experience offering clinical trials, biostatistics, medical writing, and health economics services across all phases of development.
Lindus HealthLindus Health is a clinical research organization delivering end-to-end trial execution across Phase 1–2a programs with proprietary AI-driven patient recruitment, integrated site networks, and performance-based pricing. The company has completed 45+ trials with 82% on-time enrollment and operates across the US, UK, and Europe.
Lotus Clinical ResearchSpecialized CRO supporting clinical development in neuroscience and metabolic disease across all phases, with direct access to 20 wholly-owned US research sites and 400+ beds.
MedpaceFull-service CRO with 30+ years of organic growth, offering integrated clinical development services across all phases with wholly-owned central labs, bioanalytical lab, imaging core lab, and Phase I unit.
ObvioHealthObvioHealth delivers decentralized and hybrid clinical trial solutions through its ObvioGo platform, enabling sponsors to simplify study design, boost participant engagement, and accelerate enrollment across 40 countries.
PCM TrialsWorld's largest independent, community-based clinical trial site network offering decentralized and mobile research services across diverse patient populations globally.
Markdown mirror: /services/phase-2-clinical-trials/us.md